Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic

Saudi Medical Journal

Volumn 23, Issue 9, 2002, Pages 1090-1094

  Haidar, Nassir A ^a,b  

^a Saudi Hopsital ^*  (Yemen)

^b Saudi Hospital at Hajjah   (Yemen)

Author keywords

Anti hepatitis C virus; Dialysis; Hepatitis B antigen; Liver disease

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; MONOCLONAL ANTIBODY;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HOSPITAL PERSONNEL; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; PREVALENCE; RECORDING; SCREENING TEST; YEMEN;

BLOOD DONORS; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER DISEASES; PERSONNEL, HOSPITAL; RENAL DIALYSIS; SEROEPIDEMIOLOGIC STUDIES; YEMEN;

EID: 0036756759     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Valenzuela-P. Hepatitis A, B, C, D and E viruses: structure of their genomes and general properties. Gastroenterol Jpn 1990; 25 (suppl 2): 62-71.
2. Ulrich PP, Romeo JM, Lane PK, Kelly I, Daniel LJ, Vyas GN. Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest 1990; 86: 1609-1614.
3. Fairley CK, Laslie DE, Nicholson S, Guest ID. Epidemiology and hepatitis C virus in Victoria [see comments]. Med J Aust 1990; 153: 271-273.
4. Sanchez-Quijano A, Rey C, Agugado I, Pineda JA, Perez-Romero M, Torres Y et al. Hepatitis C virus infection in sexually promiscuous groups. Eur J Clin Microbio Infect Dis 1990; 9: 610-612
5. Amarapurkar DN, Kumar A, Vaidya S, Murti P, Bichile SK, Kalro RH et al. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics. Indian J Gastroenterol 1992; 11: 80-81.
6. Mathieses LR, Skinhoj P, Hardt F, Nielsen JO, Sloth K, Zoffmann H et al. Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A non-B. Scand J Gastroenterol 1979; 14: 849-856.
7. Scheitlin T, Joller-Jemelka HI, Grob PJ. Hepatitis and HIV infection in users of illegal drugs. Schweiz Med Wochenschr 1992; 122: 1432-1445.
8. Norkrans G, Frosner G, Hermodsson S, Iwarson S. Clinical, epidemiological and prognostic aspects of hepatitis "non-A non-B" - a comparison with hepatitis A and B. Scand Infect Dis 1979; 11: 259-264.
9. Esteban JI, Gonzalez A, Hernandez JM, Viladomiu L, Sanchez C, Lopez-Talavera JC et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1107-1112.
10. Yabuuchi T, Tsukuma H, Hiyama T, Nakanishi K. Risk factors of hepatitis C virus infection. Nippon Koshu Eisei Zasshi 1993; 40: 1006-1011.
11. Chen Ds, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience [see comments]. J Infect Dis 1990; 162: 817-822.
12. Chang TT, Lin Cy, Chow NH, Hsu NH, Yang CC, Lin XZ, et al. Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan. J Formos Med Assoc 1994; 93: 128-133.
13. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: A case-control study. Liver 1994; 14: 98-102.
14. Mwangi J, Gatei DG. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya. East Afr Med J 1993; 70: 34-36.
15. Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer-Zum-Buschendfele KH et al. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Z Gastroenterol 1994; 32: 146-151.
16. Vasil'ev-LV. Reasons for the decrease in viral hepatitis morbidity in Orekhovo-Zueve. Zh Mikrobiol Epidemiol Immunobiol 1978; 3: 135-139.
17. Lucas CR, Milne A, Hopkirk N. Kawerau revisited: Hepatitis A and B seroprevalence in 1984 and 1993. N Z Med J 1994; 107: 266-268.
18. Ibarra H, Riedemann S, Gomez JC, Reinhardt G, Hochstein Mintzel V, Froesner G. Post-transfusion hepatitis in Chile: The reference parameters. Rev Med Chil 1990; 118: 134-138.
19. Suarez A, Riesstra S, Navascues CA, Sotorrio NG, Rodriguez M, Tevar F et al. Blood donors with positive HbsAg in Asturias: its current prevalence and significance. Med Clin Barc 1994; 102: 329-332.
20. Hyams KC, Cross ER, Bianco MA, Soyk-Sarty DR, Roper CM, Dahut WL et al. Geographic risk factors for viral hepatitis and cytomegalovirus infection among United States Armed Forces blood donors. Transfusion 1992; 32: 644-647.
21. Liang TJ, Bodenheimer HC Jr, Yankee R, Brown NV, Chang K, Huang J et al. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994; 42: 151-157.
22. Vasconcelos HC, Yoshida CF, Vanderborght BO, Schatzmayr HG. Hepatitis B and C prevalences among blood donors in the south region of Brazil. Mem Inst Oswaldo Cruz 1994; 89: 503-507.
23. Al Omar AS, El Zuebi F. Disease markers in blood donors at King Fahad Hospital, Al Baha. Annals of Saudi Medicine 1996; 16: 37-41.
24. Lin Chu M, Tsai SJ, Watanabe J, Nishioka K. The prevalence of anti-HCV among Chinese voluntary blood donors in Taiwan. Transfusion 1990; 30: 471-473.
25. Dazza MC, Trebucq A, Gaudebout C, Jarretou A, Le Hesran-JY, Josse R et al. Population-based study of serum hepatitis B virus DNA in Gabon. Trans R Soc Trop Med Hyg 1993; 87: 539-540.
26. Scott DA, Burans HP, Al-Ouzeib HD, Arunkumar BK, Al-Fadeel M, Nigad YR et al. A seroepidemiological survey of viral hepatitis in the Yemen Arab Republic. Trans R Soc Trop Med Hyg 1990; 84: 288-291.
27. Scott DA, Constantine NT, Callahan J, Burans JP, Olson JG, Al-Fadeel M et al. The epidemiology of hepatitis C virus antibody in Yemen. Am J Trop Med Hyg 1992; 46: 63-68.
28. El-Guneid AM, Gunaid AA, O'Neill AM, Zureikat NI, Coleman JC, Murray Lyon IM. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993; 40: 330-333.
29. Jin ZL, Chen SQ, Shi ZY. Epidemiological study of hepatitis C virus (HCV) infection in plasmapheresis and blood donors. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 1995; 16: 234-236.
30. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarathy S et al. Magnitude of hepatitis C virus infection in India: Prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997; 51: 167-174.
31. Quinti I, Renganathan E, El-Ghazzawi E, Divizia M, Sawaf G, Awad S, Pana A, Rocchi G. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 1995; 283: 239-244.
32. Petrosillo N, Puro V, Ippolito G, Di Nardo V, Albertoni F, Chiaretti B et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in health care workers: A multiple regression analysis of risk factors. J Hosp Infect 1995; 30: 273-281.
33. Jacyna MR, O'Neill K, Brown J, Drobner R, Karayiannis P, Thomas HC. Hepatitis C virus antibodies in subjects with and without liver disease in the United Kingdom. Q J Med 1990; 77: 1009-1012.
34. Boomar S, Pojanagaroon B, Watanabe Y, Tanaka Y, Saito I, Miyamura T. Prevalence of hepatitis C virus antibody among healthy blood donors and non A, non B hepatitis patients in Thailand. Jpn J Med Sci Biol 1990; 43: 29-36.
35. Van Hoof M, Waterloos H, Cornu C, De Bruyere M, Geubel AP. Anti-hepatitis C virus positivity (HCV) in Belgian volunteer blood donors: Source of contamination and HCV-testing among donors and related recipients. Acta Clin Belg 1995; 50: 335-342.
36. Song P, Duc DD, Hien B, Nakata S, Chosa T, Watanabe J et al. Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. Clin Diagn Lab Immunol 1994; 1: 413-418.
37. Ilako FM, McLigeyo SO, Riyat MS, Lule GN, Okoth FA, Kaptich D. The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J 1995; 72: 362-364.
38. Mutimer DJ, Harrison RF, O'Donnell KB, Shaw J, Martin BA, Atrah H et al. Hepatitis C virus infection in the asymptomatic British blood donor. J Viral Hepat 1995; 2: 47-53.
39. Sirchia G, Almini D, Bellobuono A, Giovanetti AM, Marconi M, Mercurriali F et al. Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group. Vox Sang 1990; 59: 26-29.
40. Stevens CE, Taylor PE, Pindyck, Choo QL, Bradley WD Kuo G et al. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA 1990; 263: 49-53.
41. Watanabe J, Minegishi K, Mitsumori T, Ishifuji M, Oguchi T, Ueda M et al. Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang 1990; 59: 86-88.
42. Hetland G, Skaug K, Larsen J, Maland A, Stromme JH, Storvold G. Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels. Transfusion 1990; 30: 776-779.
43. Aymard JP, Janot C, Adjizian C, Tamisier C, Humbert JC, Billuar M et al. Serum antibodies against hepatitis C: Study of 4100 blood donors from the northeast of France. Rev Fr Transfus Hemobiol 1990; 33: 295-302.
44. Ferroni P, Tagger A, Ribero ML, Grossi A, Pregliasco F, Pasquali ML et al. Antibodies to hepatitis C virus in blood donors. Eur J Epidemiol 1990; 6: 326-328.
45. Muller G, Zabaleta M, Caldera, LH, Bianco N, Machado IV. Hepatitis C in Venzuela. Preliminary report. GEN 1990; 44: 336-342.
46. Tan TC, Vadivale M, Ong CN. Prevalence of hepatitis B surface antigen and antibody among health care employees in Negri Sembilan, Malaysia, 1989. Asia Pac J Public Health 1992-93; 6: 134-139.
47. Figueroa JP, Carpenter H, Hospedales CJ. A survey of hepatitis B among health workers in Jamaica. West Indian Med J 1994; 43: 2-6.
48. Petrosillo N, Puro, V, Ippolito G, Di Nardo V, Albertoni F, Chiaretti B et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in health care workers: a multiple regression analysis of risk factors. J Hosp Infect 1995; 30: 273-281.
49. Daw MA, Siala IM, Warfalli MM, Muftah MI. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Saudi Med J 2000; 21: 1157-1160.
50. Rehman K, Khan AA, Haider Z, Shahzad A, Iqbal J, Khan RU et al. Prevalence of seromarkers of HBV and HCV in health care personnel and apparently healthy blood donors. J Pak Med Assoc 1996; 46: 152-154.
51. Mejia Aliaga P. Occupational exposure to hepatitis B virus in hospital personnel at the Naval Medical Center "Cirujano Mayor Santiago Tavara". Rev Gastroenterol Peru 1993; 13: 20-27.
52. Miyajima I, Sata M, Murashima S, Suzuki H, Kondo S, Ito Y et al. Prevalence of hepatitis C antibodies in health care personnel. Kansenshogaku-Zasshi 1997; 71: 103-107.
53. Schrump E, Elgjo K, Fausa O, Haujenes G, Kvale D, Rollag H. The significance of anti-hepatitis C virus antibodies measured in chronic liver disease. Scand J Gastrenterol 1990; 25: 1169-1174.
54. Ozyilkan E, Tatar G, Koseoglu, Ozkuyumcu C, Kayhan B, Telatar H. Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease. Mikrobiyol Bul 1993; 27: 308-313.
55. Leblebicioglu H, Gunaydin M, Cengiz K, Islek I. Hepatitis markers in hemodialysis patients. Mikrobiyol Bul 1993; 27: 321-326.
56. Pujol FH, Ponce JG, Lema MG, Capriles F, Devesa M, Sirit F et al. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol 1996; 34: 1633-1636.
57. Tamura I, Koda T, Kobayashi Y, Ichimura H, Kurimura O, Kurimura T. Prevalence of four blood-borne viruses (HBV, HCV, HTLV-I, HIV-1) among haemodialysis patients in Japan. J Med Virol 1992; 36: 271-273.
58. Jeffers LJ, Perez GO, de Medina MD, Ortiz Interian CJ, Schiff ER, Reddy KR et al. Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990; 38: 320-322.
59. Tokars JI, Alter MJ, Faver MS, Moyer LA, Bland LA. National surveillance of dialysis associated diseases in the United States, 1991. ASAIO J 1993; 39: 966-975.